Publisher
Springer Nature Singapore
Reference96 articles.
1. National Toxicology Program (1988) Toxicology and carcinogenesis studies of 4-hexylresorcinol (CAS no. 136-77-6) in F344/N rats and B6C3F1 mice (gavage studies). Natl Toxicol Program Tech Rep Ser 330:1–166
2. Koshiura RH, Kagotani Y, Ujiie T (1962) Experimental anticancer studies. XVI. Preparation and anticancer activity of 4-amino-6-hexylresorcinol on Ehrlich carcinoma in mice. Chem Pharm Bull 10:528–532
3. Koshimura S, Murasawa K, Nakagawa E, Ueda M, Bando Y, Hirata R (1956) Experimental anticancer studies. II. On the anti-tumor effect of 6-(2′-hydroxy-3′, 5′-dihalophenylazo)-4-hexylresorcinol and related compounds on Yoshida sarcoma and Ehrlich ascites carcinoma in vivo. Gan 47(3–4):393–397
4. Lee IS, Kim DW, Oh JH et al (2021) Effects of 4-hexylresorcinol on craniofacial growth in rats. Int J Mol Sci 22(16):8935
5. He Q, Ma P, Torshizi R (2022) The impact of some natural phenolic compounds on α-glucosidase and sorbitol dehydrogenase enzymes, and anti-leukemia cancer potential, spin density distributions, and in silico studies. J Oleo Sci 71(6):863–873